Day: August 11, 2026

Cymbalta Provided Sustained Pain Relief for Women with FIBROMYALGIA  News Release Cymbalta Provided Sustained Pain Relief for Women with Fibromyalgia Study shows improvement in pain unrelated to effect on mood and presence of major depression The antidepressant Cymbalta® (duloxetine HCl; pronounced sim-BAWL’-tuh), a dual-reuptake inhibitor of serotonin and norepinephrine, 60 mg once or twice daily, significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression, according to 12-week data presented this week at the annual meeting of the American College of Rheumatology. These data…

Read More

FDA Approves First New Fibromyalgia Drug in 15 Year By Pat Anson Fibromyalgia sufferers who have yearned for new treatments finally have one. Tonix Pharmaceuticals says the Food and Drug Administration has approved Tonmya for the treatment of fibromyalgia in adults — the first new FDA-approved therapy for fibromyalgia in over 15 years. Fibromyalgia is a poorly understand chronic pain condition that affects about 10 million Americans, most of them women. It causes an array of symptoms, such as widespread body aches, fatigue, insomnia, mood disorders and brain fog. Until…

Read More